Hereditary Leiomyomatosis and Renal Cell Cancer - 3 Studies Found
Recruiting |
: A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer :
: 2010-05-25 :
|
Completed |
: Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin :
|
Recruiting |
: Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma :
|